Latest News
Gyre Therapeutics, Inc.
- Gyre Therapeutics, Inc. Estimates – NASDAQ:GYRE
- Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
- Gyre Therapeutics signs new employment agreements with CEO Ying Luo and CFO Thomas Eastling
- H.C. Wainwright reiterates USD 18.00 target for Gyre Therapeutics stock
- Gyre Therapeutics stock falls 5.00 percent to USD 6.08 on October 16, 2026
- H.C. Wainwright keeps USD 18.00 target for Gyre Therapeutics stock
- Gyre Therapeutics stock gains 1.57 percent after upgrade
Headlines from the last 30 days, linking to the original publishers. See all market news →